Vir Biotechnology Inc (NASDAQ:VIR)

Stock Price: $26.05

+0.28 (1.09%)

Updated May 26, 2023 08:00 PM GMT+0000

Featured app

Invest now

77% of retail CFD accounts lose money.

Overview

Financials

Statistics

Profile

Chart

Market Cap	3.49B
Revenue	815.97M
Gross Profit	757.90M
Shares Out	133.98M
EPS (ttm)	-1.07
PE Ratio	-24.2900
Forward PE	-7.4443
Dividend Rate (ttm)	0.0000
Dividend Yield	0.0000

Trading Day	May 26
Last Price	$26.05
Previous Close	$25.77
Change ($)	0.28
Change (%)	1.09%
Day's Open	25.81
Day's Range	25.66 - 26.28
Day's Volume	618.15K
52 Week Range	18.05 - 31.78

About Vir Biotechnology Inc

Vir Biotechnology is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes.

Its current development pipeline consists of product candidates targeting SARS-CoV-2, hepatitis B virus, influenza A, human immunodeficiency virus and tuberculosis.

News

This biotech stock could double from here: Goldman Sachs February 21, 2023

Vir Biotechnology gains 10% after receiving EUA for its COVID-19 treatment May 27, 2021

Quick info

Industry

Research and Development in Biotechnology

Sector

Professional, Scientific, and Technical Services

Employees

576

Website

www.vir.bio

Ticker Symbol

VIR

Exchange

NASDAQ Stock Exchange

Reporting Currency

USD

Vir Biotechnology Inc income statements (2022) (USD)

	August 2022	August 2022	May 2022	February 2022
Total Revenue	-40.63M	-40.63M	1.23B	1.10B
Cost of Revenue	27.92M	27.92M	90.15M	65.87M
Gross Profit	-68.55M	-68.55M	1.14B	1.03B
Research & Development	115.08M	115.08M	90.23M	448.01M
Selling General & Admin	41.59M	41.59M	38.26M	160.79M
Operating Expense	184.59M	184.59M	218.63M	674.66M
Operating Income	-225.22M	-225.22M	1.01B	420.75M
Other Income Expense Net	0	0	0	0
EBIT	-225.22M	-225.22M	1.01B	420.75M
Interest Income	-2.2M	-2.2M	-388K	-439K
Pretax Income	-233.72M	-233.72M	0.92B	549.80M
Income Tax	-157.23M	-157.23M	403.29M	21.22M
Minority Interest	0	0	0	0
Net Income	-76.49M	-76.49M	518.62M	528.58M
Net Income Basic	-76.49M	-76.49M	518.62M	528.58M

Vir Biotechnology Inc income statements (2021) (USD)

	November 2021	August 2021	May 2021	February 2021
Total Revenue	103.62M	177.07M	1.98M	76.37M
Cost of Revenue	7.84M	1.14M	0	0
Gross Profit	95.78M	175.92M	1.98M	76.37M
Research & Development	98.67M	86.13M	134.87M	302.41M
Selling General & Admin	50.50M	28.78M	25.74M	70.94M
Operating Expense	157M	116.05M	160.61M	373.35M
Operating Income	-53.39M	61.02M	-158.63M	-296.98M
Other Income Expense Net	0	0	0	0
EBIT	-53.39M	61.02M	-158.63M	-296.98M
Interest Income	-11K	-97K	-164K	-2.84M
Pretax Income	110.76M	61.87M	-168.72M	-298.61M
Income Tax	334K	53K	196K	54K
Minority Interest	0	0	0	0
Net Income	110.43M	61.81M	-168.91M	-298.67M
Net Income Basic	110.43M	61.81M	-168.91M	-298.67M

Vir Biotechnology Inc income statements (2020) (USD)

	June 2020	June 2020	March 2020	March 2020
Total Revenue	N.A	N.A	N.A	N.A
Cost of Revenue	N.A	N.A	N.A	N.A
Gross Profit	N.A	N.A	N.A	N.A
Research & Development	77.42M	77.42M	57.16M	57.16M
Selling General & Admin	16.39M	16.39M	12.65M	12.65M
Operating Expense	N.A	N.A	N.A	N.A
Operating Income	-29.05M	-29.05M	-66.21M	-66.21M
Other Income Expense Net	-2.07M	-2.07M	-11.01M	-11.01M
EBIT	-29.05M	-29.05M	-66.21M	-66.21M
Interest Income	N.A	N.A	N.A	N.A
Pretax Income	-31.12M	-31.12M	-77.22M	-77.22M
Income Tax	46K	46K	16K	16K
Minority Interest	0	0	0	0
Net Income	-31.17M	-31.17M	-77.24M	-77.24M
Net Income Basic	-31.17M	-31.17M	-77.24M	-77.24M

Vir Biotechnology Inc income statements (2019) (USD)

	December 2019	September 2019
Total Revenue	N.A	N.A
Cost of Revenue	N.A	N.A
Gross Profit	N.A	N.A
Research & Development	48.11M	38.19M
Selling General & Admin	11.81M	9.22M
Operating Expense	N.A	N.A
Operating Income	-60.1M	-47.21M
Other Income Expense Net	-3.52M	-1.12M
EBIT	-60.1M	-47.21M
Interest Income	N.A	N.A
Pretax Income	-63.62M	-48.33M
Income Tax	149K	-13K
Minority Interest	0	0
Net Income	-63.77M	-48.31M
Net Income Basic	-63.77M	-48.31M

Vir Biotechnology Inc income statements (2018) (USD)

	September 2018
Total Revenue	N.A
Cost of Revenue	N.A
Gross Profit	N.A
Research & Development	29.13M
Selling General & Admin	7.39M
Operating Expense	N.A
Operating Income	-34.35M
Other Income Expense Net	890K
EBIT	-34.35M
Interest Income	N.A
Pretax Income	-33.46M
Income Tax	N.A
Minority Interest	0
Net Income	-33.46M
Net Income Basic	-33.46M

Vir Biotechnology Inc balance sheet (2023) (USD)

	February 2023
Current Cash	2.37B
Receivables	0
Inventory	0
Current Assets	2.52B
Other Current Assets	86.74M
Short Term Investments	118.63M
Long Term Investments	283.01M
Property/Plant Equipment	105.61M
Good Will	N.A
Intangible Assets	32.76M
Tangible Assets (Net)	2.03B
Other Assets	14.57M
Total Assets	2.80B
Accounts Payable	6.42M
Other Current Liabilities	504.61M
Total Current Liabilities	511.03M
Total Liabilities	724.13M
Long Term Debt	0
Current Long Term Debt	0
Minority Interest	0
Common Stock	133.17M
Treasury Stock	0
Retained Earnings	377.24M
Capital Surplus	N.A
Shareholder Equity	2.08B
Other Liabilities	N.A

Vir Biotechnology Inc balance sheet (2022) (USD)

	August 2022	August 2022	May 2022	February 2022
Current Cash	2.16B	2.16B	1.21B	565M
Receivables	7M	7M	1.22B	773.08M
Inventory	0	0	0	0
Current Assets	2.29B	2.29B	2.57B	1.56B
Other Current Assets	72.42M	72.42M	69.91M	73M
Short Term Investments	108.82M	108.82M	117.80M	216.15M
Long Term Investments	330.73M	330.73M	319.58M	391.45M
Property/Plant Equipment	85.14M	85.14M	65.58M	42.83M
Good Will	N.A	N.A	N.A	N.A
Intangible Assets	33.02M	33.02M	33.15M	33.29M
Tangible Assets (Net)	1.90B	1.90B	1.95B	1.38B
Other Assets	2.82M	2.82M	3M	2.78M
Total Assets	2.62B	2.62B	2.89B	1.95B
Accounts Payable	10.62M	10.62M	10.96M	6.52M
Other Current Liabilities	467.25M	467.25M	691.41M	334.72M
Total Current Liabilities	477.87M	477.87M	702.36M	341.24M
Total Liabilities	666.98M	666.98M	886.12M	522.42M
Long Term Debt	0	0	0	0
Current Long Term Debt	0	0	0	0
Minority Interest	0	0	0	0
Common Stock	132.45M	132.45M	132.08M	129.88M
Treasury Stock	0	0	0	0
Retained Earnings	303.53M	303.53M	380.02M	-138.6M
Capital Surplus	N.A	N.A	N.A	N.A
Shareholder Equity	1.95B	1.95B	2B	1.43B
Other Liabilities	N.A	N.A	N.A	N.A

Vir Biotechnology Inc balance sheet (2021) (USD)

	November 2021	August 2021	May 2021	February 2021
Current Cash	770.08M	826.06M	733.03M	736.86M
Receivables	93M	0	112.50M	0
Inventory	0	0	0	0
Current Assets	1.07B	862.30M	0.99B	772.37M
Other Current Assets	27.77M	18.95M	131.07M	19.60M
Short Term Investments	197.14M	18.95M	131.07M	19.60M
Long Term Investments	143.88M	195.29M	142.47M	146.40M
Property/Plant Equipment	26.61M	20.25M	17.29M	17.95M
Good Will	N.A	N.A	N.A	N.A
Intangible Assets	33.42M	33.55M	33.69M	33.82M
Tangible Assets (Net)	825.92M	686.83M	600.33M	666.10M
Other Assets	2.34M	7.89M	7.10M	8.83M
Total Assets	1.21B	1.06B	1.14B	0.92B
Accounts Payable	4.23M	11.03M	3.70M	5.08M
Other Current Liabilities	229.50M	134.99M	357.40M	93.72M
Total Current Liabilities	233.72M	146.02M	361.10M	99.06M
Total Liabilities	333.94M	320.26M	484.63M	201.91M
Long Term Debt	0	0	0	0
Current Long Term Debt	0	0	0	265K
Minority Interest	0	0	0	0
Common Stock	130.67M	130.12M	127.74M	119.16M
Treasury Stock	0	0	0	0
Retained Earnings	-663.85M	-774.28M	-836.1M	-667.18M
Capital Surplus	N.A	N.A	N.A	N.A
Shareholder Equity	876.27M	737.33M	650.95M	716.85M
Other Liabilities	N.A	N.A	N.A	N.A

Vir Biotechnology Inc balance sheet (2020) (USD)

	June 2020	March 2020	March 2020
Current Cash	382.81M	177.52M	177.52M
Receivables	N.A	N.A	N.A
Inventory	N.A	N.A	N.A
Current Assets	578.76M	377.54M	377.54M
Other Current Assets	11.56M	12.83M	12.83M
Short Term Investments	180.60M	187.19M	187.19M
Long Term Investments	6.89M	13.03M	13.03M
Property/Plant Equipment	31.49M	32.25M	32.25M
Good Will	N.A	N.A	N.A
Intangible Assets	35.08M	35.39M	35.39M
Tangible Assets (Net)	546.84M	363.40M	363.40M
Other Assets	3.08M	1.97M	1.97M
Total Assets	672.24M	477.11M	477.11M
Accounts Payable	4.38M	18.77M	18.77M
Other Current Liabilities	47.18M	34.22M	34.22M
Total Current Liabilities	54.94M	56.40M	56.40M
Total Liabilities	108.46M	96.78M	96.78M
Long Term Debt	13.56M	14.33M	14.33M
Current Long Term Debt	244K	240K	240K
Minority Interest	0	0	0
Common Stock	117.73M	108.35M	108.35M
Treasury Stock	N.A	N.A	N.A
Retained Earnings	-476.93M	-445.76M	-445.76M
Capital Surplus	1.04B	825.83M	825.83M
Shareholder Equity	563.78M	380.33M	380.33M
Other Liabilities	N.A	N.A	N.A

Vir Biotechnology Inc balance sheet (2019) (USD)

	December 2019	September 2019
Current Cash	115.52M	102.52M
Receivables	N.A	N.A
Inventory	N.A	N.A
Current Assets	403M	337.72M
Other Current Assets	13.38M	8.69M
Short Term Investments	274.10M	226.51M
Long Term Investments	38.19M	9.45M
Property/Plant Equipment	16.31M	15.45M
Good Will	N.A	N.A
Intangible Assets	35.69M	36M
Tangible Assets (Net)	351.84M	-297.73M
Other Assets	1.95M	7.09M
Total Assets	512.07M	422.64M
Accounts Payable	5.88M	5.82M
Other Current Liabilities	53.09M	38.30M
Total Current Liabilities	59.21M	44.32M
Total Liabilities	88.13M	703.44M
Long Term Debt	0.90M	637.51M
Current Long Term Debt	237K	200K
Minority Interest	0	0
Common Stock	107.65M	109.68M
Treasury Stock	N.A	N.A
Retained Earnings	-368.52M	-304.75M
Capital Surplus	793.05M	23.87M
Shareholder Equity	423.94M	-280.8M
Other Liabilities	N.A	N.A

Vir Biotechnology Inc cash flow (2023) (USD)

	February 2023
Net Income	-101.6M
Depreciation	1.95M
Changes in Receivables	0
Changes in Inventories	0
Cash Change	2.37B
Cash Flow	35.13M
Capital Expenditures	-12.6M
Investments	N.A
Investing Activity (other)	N.A
Total Investing Cash Flows	-153.14M
Dividends Paid	N.A
Net Borrowings	-2.49B
Other Financing Cash Flows	N.A
Cash Flow Financing	2.01M
Exchange Rate Effect	N.A

Vir Biotechnology Inc cash flow (2022) (USD)

	November 2022	August 2022
Net Income	175.31M	-76.49M
Depreciation	1.68M	1.60M
Changes in Receivables	0	7M
Changes in Inventories	0	0
Cash Change	2.32B	2.16B
Cash Flow	117.90M	0.96B
Capital Expenditures	-18.99M	-20.6M
Investments	N.A	N.A
Investing Activity (other)	N.A	N.A
Total Investing Cash Flows	-662.61M	-272.33M
Dividends Paid	N.A	N.A
Net Borrowings	-2.4B	-2.27B
Other Financing Cash Flows	N.A	N.A
Cash Flow Financing	1.99M	3.08M
Exchange Rate Effect	N.A	N.A

Vir Biotechnology Inc cash flow (2021) (USD)

	November 2021
Net Income	110.43M
Depreciation	1.49M
Changes in Receivables	93M
Changes in Inventories	0
Cash Change	770.08M
Cash Flow	-105.81M
Capital Expenditures	-6.01M
Investments	N.A
Investing Activity (other)	N.A
Total Investing Cash Flows	73.86M
Dividends Paid	N.A
Net Borrowings	-0.97B
Other Financing Cash Flows	N.A
Cash Flow Financing	3.63M
Exchange Rate Effect	N.A

Vir Biotechnology Inc cash flow (2020) (USD)

	June 2020	March 2020
Net Income	-31.17M	-77.24M
Depreciation	2.20M	2.12M
Changes in Receivables	N.A	N.A
Changes in Inventories	N.A	N.A
Cash Change	205.29M	55.90M
Cash Flow	-9.84M	-47.65M
Capital Expenditures	-1.34M	-1.3M
Investments	11.93M	105.34M
Investing Activity (other)	N.A	N.A
Total Investing Cash Flows	10.59M	104.22M
Dividends Paid	N.A	N.A
Net Borrowings	-853K	-819K
Other Financing Cash Flows	-3.55M	N.A
Cash Flow Financing	204.54M	-676K
Exchange Rate Effect	N.A	N.A

Vir Biotechnology Inc cash flow (2019) (USD)

	December 2019
Net Income	-63.77M
Depreciation	1.16M
Changes in Receivables	N.A
Changes in Inventories	N.A
Cash Change	17.45M
Cash Flow	-38.89M
Capital Expenditures	-1.55M
Investments	-72.22M
Investing Activity (other)	N.A
Total Investing Cash Flows	-73.77M
Dividends Paid	N.A
Net Borrowings	-57K
Other Financing Cash Flows	-3K
Cash Flow Financing	130.10M
Exchange Rate Effect	N.A

Vir Biotechnology Inc cash flow (2018) (USD)

	September 2018
Net Income	-33.46M
Depreciation	N.A
Changes in Receivables	N.A
Changes in Inventories	N.A
Cash Change	N.A
Cash Flow	N.A
Capital Expenditures	N.A
Investments	N.A
Investing Activity (other)	N.A
Total Investing Cash Flows	N.A
Dividends Paid	N.A
Net Borrowings	N.A
Other Financing Cash Flows	N.A
Cash Flow Financing	N.A
Exchange Rate Effect	N.A